Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2023
Filter by date:
Showing 1262 press releases before 2023
-
Calquence significantly prolonged the time patients lived without disease progression or death in previously untreated chronic lymphocytic leukaemia
-
Calquence significantly prolonged the time patients lived without disease progression or death in previously untreated chronic lymphocytic leukaemia
-
Lynparza approved in China as a 1st-line maintenance therapy in BRCA-mutated advanced ovarian cancer
-
AstraZeneca divests rights to Seroquel and Seroquel XR in the US and Canada
-
Imfinzi granted FDA Priority Review for the treatment of patients with extensive-stage small cell lung cancer
-
Calquence approved in the US for adult patients with chronic lymphocytic leukaemia
-
Harvard Business Review names Pascal Soriot among ‘Best Performing Top 100 CEOs in the World’ 2019
-
Qtrilmet approved in the EU for the treatment of type-2 diabetes
-
US FDA accepts regulatory submission for selumetinib in neurofibromatosis type 1 and grants Priority Review
-
Anifrolumab demonstrated superiority across multiple efficacy endpoints in patients with systemic lupus erythematosus in Phase III TULIP 2 trial
Latest articles and press releases
All of our latest press releases and articles are available to explore
Use a maximum of two downloads here
